PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Clinical trials for PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR trials appear

Sign up with your email to follow new studies for PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Bladder-Saving cancer treatment shows promise

Disease control Ongoing

This study is testing a treatment plan for muscle-invasive bladder cancer that aims to avoid major surgery. It combines chemotherapy, an immunotherapy drug (toripalimab), and radiation therapy to try to eliminate the cancer while preserving the patient's bladder. The main goals a…

Matched conditions: PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR

Get alerted when new PROGRAMMED CELL DEATH PROTEIN 1 INHIBITOR trials appear

New Bladder-Saving cancer treatment shows promise